PCI PROVIDES COSTLY MORTALITY REDUCTIONS FOR BREAST CANCER PATIENTS: PROPENSITY SCORE AND MACHINE LEARNING AUGMENTED NATIONALLY REPRESENTATIVE CASE-CONTROL STUDY OF 30 MILLION+ HOSPITALIZATIONS

Since the optimal management of coronary artery disease (CAD) and breast cancer is unknown, we sought to conduct the first known nationally representative study of mortality and cost effectiveness for breast cancer and percutaneous coronary interventions (PCI). Backward propagation neural...